Author

Michael Morse

Boston Children's HospitalPrimary ORCID profile (0000-0002-8561-1833 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Michael MorseiD1 paper · Broad Institute

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Assay:ChIP-seq· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Allison Tompkins· 1 shared Anup VaidyaiD· 1 shared Arianna MarkeliD· 1 shared Benoît LaurentiD· 1 shared Bjoern ChapuyiD· 1 shared Caroline KubaczkaiD· 1 shared Cheng ZhangiD· 1 shared Christopher LiiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Allison Tompkins

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mechanism of SARS-CoV-2 Nucleocapsid Protein Phosphorylation-induced Functional Switch

Megan S. Sullivan, Michael Morse, Kaylee Grabarkewitz, Dina Bayachou, Ioulia F. Rouzina, Vicki Hopper Wysocki, Mark C. Williams, Karin Musier‐Forsyth

This study investigates how phosphorylation of SARS-CoV-2 Np's SRR linker affects its RNA binding and packaging functions through biophysical and biochemical analyses.

Viruses · Jan 13, 2026Peer-reviewedBiochemistry

Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers

Mohamad Ali Toufic Najia, Deepak Kumar Jha, Cheng Zhang, Benoît Laurent, Caroline Kubaczka, Arianna Markel, Christopher Li, Vivian Morris, Allison Tompkins, Luca T. Hensch, Yue Qin, Bjoern Chapuy, Yu-Chung Huang, Michael Morse, Matthew R. Marunde, , George Q. Daley

The paper identifies KDM4 demethylase inhibition as a therapeutic strategy for lymphoma and other cancers by rewiring heterochromatin and inducing DNA damage.

bioRxiv · Jan 31, 2025 · PreprintGenomics